2022
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
Bharat Biotech
|
|
|
Bharat Pharma
|
|
|
GENoMiX
|
|
|
Serum Institute of India
|
Detailed explanation-1: -Department of Biotechnology (DBT) and its PSU, Biotechnology Industry Research Assistance Council (BIRAC) is delighted to announce approval from DCGI for emergency use authorization first of its kind intranasal COVID-19 Vaccine to Bharat Biotech (BBIL).
Detailed explanation-2: -Union Minister Dr Jitendra Singh lauds the role of Department of Biotechnology (DBT) for supporting the development of world’s first Intranasal vaccine for COVID by Bharat Biotech International Limited (BBIL)
Detailed explanation-3: -BBV154 - A novel adenovirus vectored, intranasal vaccine for COVID-19.
Detailed explanation-4: -The world’s first intranasal COVID-19 vaccine, iNCOVACC by Bharat Biotech, is looking at a launch in India by this month end. So far, however, only corporate hospitals in major cities have shown interest in procuring the vaccine, as demand for booster doses remains low.